Your browser doesn't support javascript.
loading
A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis.
Mumford, Andrew D; Dawood, Ban B; Daly, Martina E; Murden, Sherina L; Williams, Michael D; Protty, Majd B; Spalton, Jennifer C; Wheatley, Mark; Mundell, Stuart J; Watson, Steve P.
Affiliation
  • Mumford AD; Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom. a.mumford@bristol.ac.uk
Blood ; 115(2): 363-9, 2010 Jan 14.
Article in En | MEDLINE | ID: mdl-19828703
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Platelets / Mutation, Missense / Receptors, Thromboxane A2, Prostaglandin H2 / Hemorrhagic Disorders Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Animals / Female / Humans / Male Language: En Journal: Blood Year: 2010 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Platelets / Mutation, Missense / Receptors, Thromboxane A2, Prostaglandin H2 / Hemorrhagic Disorders Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Animals / Female / Humans / Male Language: En Journal: Blood Year: 2010 Document type: Article Affiliation country: United kingdom Country of publication: United States